United States · FDA National Drug Code directory
Paclitaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-255_5f3284c1-d03f-4fca-bb78-1ead3280af60
- Product NDC
- 25021-255
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Paclitaxel
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240201
- Source listing expiry
- 20261231
Source-listed ingredients
- PACLITAXEL — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-255-05) / 5 mL in 1 VIAL · 25021-255-05
- 1 VIAL in 1 CARTON (25021-255-17) / 16.7 mL in 1 VIAL · 25021-255-17
- 1 VIAL in 1 CARTON (25021-255-50) / 50 mL in 1 VIAL · 25021-255-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →